Italian Life Sciences Database

NORTHFIELD, Ill. and IRVINE, Calif., June 24, 2020 /PRNewswire/ -- Many states have reopened amidst the COVID-19 pandemic, and elective surgeries are starting back up. As ambulatory surgery centers (ASCs) open their doors again, they are now tasked with figuring out how to update all of their... Read more ››

By: PR Newswire Association LLC. - 24 Jun 2020

Philogen Received Combination Pack Approval for Nidlegy

SIENA, Italy, June 24, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, on Jan. 30, 2020, EMA's CHMP expressed a favorable opinion to the request of a combination pack for the to-be-marketed pharmaceutical form of Nidlegy(TM), a combination... Read more ››

By: PR Newswire Association LLC. - 24 Jun 2020

Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients

By: GlobenewsWire - 23 Jun 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 22 Jun 2020

Sanofi: Information concerning the total number of voting rights and shares - May 2020

By: GlobenewsWire - 19 Jun 2020

Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors

By: GlobenewsWire - 19 Jun 2020

Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination trial with AM833 and semaglutide in obesity

By: GlobenewsWire - 18 Jun 2020

RECORDATI: ISTURISA® (OSILODROSTAT) PHASE III LINC-4 TRIAL MEETS ITS PRIMARY ENDPOINT IN CUSHING’S DISEASE

By: GlobenewsWire - 17 Jun 2020

Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease

By: GlobenewsWire - 16 Jun 2020

Sanofi invests to make France its world class center of excellence in vaccine research and production

By: GlobenewsWire - 16 Jun 2020

Medit Celebrates 20th Anniversary and Appoints GB (Gyu Bum) Ko as New CEO to Accelerate Growth Strategy

SEOUL, South Korea, June 16, 2020 /PRNewswire/ -- Medit announces the nomination of its new Chief Executive Officer, GB (Gyu Bum) Ko, amidst the company's 20(th) year as a global provider of 3D scanning solutions. Ko joins Medit to accelerate its growth strategy as a leader in the dental... Read more ››

By: PR Newswire Association LLC. - 16 Jun 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 15 Jun 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

August 2020
- ChinaBio® Partnering Forum 2020 Digital
- Biotechgate Digital Partnering Event
September 2020
- Basel: Pharma-Biotech Product & Company Valuation

See Events »

Add an Event »

Latest company news

Six-month interim report (Q2) 2020
12 Aug 2020 (GlobenewsWire)

Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020
06 Aug 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
05 Aug 2020 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news